Skip to main content

Table 2 Mean values and time by treatment interaction results of primary outcome measures*

From: A treatment applying a biomechanical device to the feet of patients with knee osteoarthritis results in reduced pain and improved function: a prospective controlled study

Outcome

Baseline

Follow-up

(4 weeks)

Final

(8 weeks)

P Value†

WOMAC - Pain

   Active

5.4 ± 2.7

3.1 ± 2.2

1.9 ± 1.6

<0.001

   Control

5.0 ± 2.7

5.1 ± 2.2

5.4 ± 2.7

 

   P Value

0.50

0.002

<0.001

 

WOMAC - Stiffness

   Active

5.7 ± 3.0

3.7 ± 2.5

1.9 ± 2.3

<0.001

   Control

5.4 ± 3.3

5.4 ± 3.0

5.2 ± 3.2

 

   P Value

0.67

0.02

<0.001

 

WOMAC - Function

   Active

5.1 ± 2.6

3.1 ± 1.9

1.9 ± 1.5

<0.001

   Control

5.2 ± 2.3

5.5 ± 2.2

5.7 ± 2.6

 

   P Value

0.91

<0.001

<0.001

 

WOMAC - Total Score

   Active

5.4 ± 2.6

3.3 ± 2.0

1.9 ± 1.7

<0.001

   Control

5.2 ± 2.6

5.3 ± 2.3

5.4 ± 2.6

 

   P value

0.71

0.001

<0.001

 

ALF Score

   Active

36.9 ± 11.5

29.2 ± 8.8

25.3 ± 6.6

<0.001

   Control

39.2 ± 16.7

37.7 ± 15.5

38.5 ± 16.3

 

   P value

0.56

0.01

<0.001

 
  1. * Primary outcome measures: Western Ontario and McMaster Osteoarthritis Index (WOMAC) questionnaire (0-10 cm Scale) and Aggregated locomotor function (ALF) (sec.). Mean values are presented as mean ± SD.
  2. † The vertical p-value represent the time by treatment interaction results. This represents the difference between the groups at different points in time. The horizontal p-value represents group differences in the three examination points. This represents the differences in the active group across the three follow-ups. No significant differences were found in the control group.